{"id":"NCT01239797","sponsor":"Bristol-Myers Squibb","briefTitle":"Phase III Study of Lenalidomide and Dexamethasone With or Without Elotuzumab to Treat Relapsed or Refractory Multiple Myeloma","officialTitle":"Phase 3, Randomized, Open Label Trial of Lenalidomide/Dexamethasone With or Without Elotuzumab in Relapsed or Refractory Multiple Myeloma (MM)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2011-06-20","primaryCompletion":"2014-09-02","completion":"2021-04-21","firstPosted":"2010-11-11","resultsPosted":"2017-01-05","lastUpdate":"2022-06-01"},"enrollment":646,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Lymphoma","Multiple Myeloma"],"interventions":[{"type":"DRUG","name":"Lenalidomide","otherNames":["Revlimid®"]},{"type":"DRUG","name":"Dexamethasone","otherNames":["Decadron®","Dexamethasone Intensol®","Dexpak®","Taperpak®"]},{"type":"DRUG","name":"Dexamethasone (Oral)","otherNames":["Decadron®","Dexamethasone Intensol®","Dexpak®","Taperpak®"]},{"type":"DRUG","name":"Dexamethasone (IV)","otherNames":["Decadron®","Dexamethasone Intensol®","Dexpak®","Taperpak®"]},{"type":"BIOLOGICAL","name":"Elotuzumab (BMS-901608; HuLuc63)","otherNames":[]}],"arms":[{"label":"Lenalidomide + Dexamethasone","type":"ACTIVE_COMPARATOR"},{"label":"Lenalidomide + Dexamethasone +Elotuzumab","type":"EXPERIMENTAL"}],"summary":"The purpose of the study is to determine whether the addition of Elotuzumab to Lenalidomide/low-dose Dexamethasone will increase the progression free survival (PFS).","primaryOutcome":{"measure":"Median Progression Free Survival (PFS)","timeFrame":"From randomization up to 326 events (up to approximately 38 months)","effectByArm":[{"arm":"Lenalidomide + Dexamethasone + Elotuzumab","deltaMin":19.35,"sd":null},{"arm":"Lenalidomide + Dexamethasone","deltaMin":14.85,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.0014"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":5,"exclusionCount":3},"locations":{"siteCount":216,"countries":["United States","Australia","Austria","Belgium","Canada","Czechia","Denmark","France","Germany","Greece","Hungary","Ireland","Israel","Italy","Japan","Poland","Puerto Rico","Romania","Spain","Switzerland","Turkey (Türkiye)","United Arab Emirates","United Kingdom"]},"refs":{"pmids":["30204239","28070715","26035255"],"seeAlso":["https://www.bms.com/researchers-and-partners/clinical-trials-and-research.html","https://www.bmsstudyconnect.com/s/US/English/USenHome","https://www.bms.com/researchers-and-partners/investigator-inquiry-form.html","https://www.fda.gov/Safety/MedWatch/SafetyInformation/default.htm"]},"adverseEventsSummary":{"seriousAny":{"events":238,"n":318},"commonTop":["Fatigue","Diarrhoea","Anaemia","Neutropenia","Constipation"]}}